BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 5, 2007
View Archived Issues
Novel oncolytic drugs revealed in recent patents
Read More
Merck & Co. reports third quarter 2007 results
Read More
Recent patents disclose new antiinfective agents
Read More
Antisense oligonucleotide reverses myotonia in mouse models of MD
Read More
Recent ACRAF patent discloses new antipyretic agents
Read More
HDAC5 function in nucleus accumbens altered by chronic cocaine and stress
Read More
Addex and Merck & Co. collaboration for Parkinson's disease
Read More
Novartis and MorphoSys form new strategic alliance
Read More
Acorda completes enrollment of phase III clinical trial of Fampridine-SR
Read More
Abbott makes Aluvia available to Ugandan children with HIV/AIDS
Read More
TopoTarget reports positive results from phase II clinical trial of Baceca
Read More
Buck Institute and Neurobiological Technologies to develop FGF-2 drug for HD
Read More
GW Pharmaceuticals initiates phase III clinical trial of Sativex for MS spasticity
Read More
InSite Vision files new drug submission with Health Canada for AzaSite for conjunctivitis
Read More
FDA accepts Repros' proposal to initiate phase III studies of Proellex for uterine fibroids
Read More
FDA accepts Cephalon's NDA for Treanda in chronic lymphocytic leukemia
Read More
AstraZeneca completes enrollment in phase III ZEST study of Zactima for NSCLC
Read More
AVI-4658 granted fast track status for Duchenne muscular dystrophy
Read More
Can-Fite submits IND application to the FDA to initiate phase I clinical trials with CF-102
Read More
Medtronic files premarket approval application with FDA for Talent
Read More
Ono reports first half ended September 30, 2007 R&D highlights
Read More
Novel treatments for urological disorders reported in recent Astellas and Mitsubishi Tanabe patents
Read More
Recent Japan Tobacco patent discloses novel therapeutic agents for HCV infection
Read More
Centocor and Janssen-Cilag seek approval for ustekinumab from FDA and EMEA
Read More
EMEA accepts for filing UCB's MAA for Neupro for restless legs syndrome
Read More